Quarterly report pursuant to Section 13 or 15(d)

Investment (Details)

v3.22.1
Investment (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Sep. 30, 2021
Schedule of Equity Method Investments [Line Items]          
Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr         $ 99,020
DepYmed preferred shares received in sale of intellectual property         316,724
DepYmed preferred shares received in sale of intellectual property     $ 0 $ 316,724  
Total Investment         $ 415,744
DepYmed          
Schedule of Equity Method Investments [Line Items]          
Percentage of ownership held 15.00%   15.00%    
Equity in losses on equity method investment $ (0.0) $ 40,000.00 $ 400,000 $ 60,000.00